That's important, due to the fact that the method a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we need to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (jeff brown prediction for 2021). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was an advancement practically no one noticed. However it's going to have extensive implications for curing illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of investment chances in this space, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (white house). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps considerably prior to going higher - jeff brown latest prediction. I have actually been covering bitcoin for a long period of time now. Among the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were primarily educating readers. However that's not the big concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old institution. So think about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. future report. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of fantastic private companies on the brink of striking the general public markets And I've been dealing with a brand-new method for you to invest even before these business go public.
This chance has actually been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your spot totally free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers understand that tech isn't our typical beat (jeff brown investment prediction). And when it pertains to tech investing, we leave it to the experts. Fortunately, we have numerous such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we understand (brownstone research). In reality, he had several triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing rapid development and developing amazing chances for investors. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. diplomatic relations. However in spite of what many readers might believe, this is a trend that's just getting going. Although the COVID-19 pandemic interfered with supply chains in 2015, an outstanding 250 million 5G-enabled devices were still offered.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown stock market prediction). Losing 2 months of production and sales truly impacts the number of 5G gadgets are offered in the fiscal year. When you consider all of that, offering 250 million units is exceptional. More significantly, the hold-ups brought on by the pandemic created a lots of bottled-up need. And that need is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - exponential growth. And that's not my only 5G forecast When I've discussed 5G in the past, I've explained its three different phases.
In Phase 2, 5G devices go on sale. 5G phones and other products begin to reach consumers. And in Phase 3, 5G services start to be offered (jeff brown stock predictions). That's when we begin to see applications operating on 5G networks. Think of things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage Three by this summer season. This starts something of a virtuous cycle: The majority of people do not really care about the innovation. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open up a suite of unbelievable applications: self-driving vehicles, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next important technology I visualize in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it's one of the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not work correctly. CRISPR utilizes a comparable idea however with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For many years, CRISPR was primarily a specific niche innovation that wasn't well understood. And throughout that time, there were truly just three business running in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with diseases and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This whole market is efficiently a greenfield opportunity.
There's room for lots of companies to exist in this area. biotech stock. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can accurately predict the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is very important due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has been an experimental procedure. Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug treatments produced using this technology. This was one of those breakthroughs that almost no one saw. However it's going to have profound implications for treating illness. And, of course, there will be plenty of financial investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it drew back maybe significantly prior to going greater. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever published was on bitcoin - jeff brown biotech picks. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my recommendation. However at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. last week. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the info depends on date as of February 2021, but we might not independently validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down a precise figure at this minute. Brown is best known for his sage-like capability to choose winning technology stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an excellent viewpoint on the market. He's always on the hunt for new chances, and he shares much of his finest picks in the Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an exceptional track record as a stock-picker, and he successfully anticipated some of the greatest financial events of the past twenty years. Although he does not appear to release his choices to the public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal whenever, however Jeff Brown's accurate forecasts have actually earned him legions of devoted followers. That says a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular financial research publisher. Brownstone Research provides several research study services with a wide range of specializations - jeff brown 1 biotech.
The company is also connected with Bonner & Partners, another well-respected research publisher - jeff brown genome sequencing stock. On its website, Brownstone says its objective is to supply retail financiers with professional-grade research study: "For too long, the very best investment research study has actually not been offered to private financiers. It has been normally reserved for financial investment banks, hedge funds, personal equity, and high-net-worth clients. last week. The mission of Brownstone Research is to make that kind of exclusive research available to any financiers wanting to gain an edge in the marketplaces. The objective is simple to provide special and lucrative investment research study discovered nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also functions as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you understand even a bit about the market, you understand that he has a reputation as a King Midas of sorts. united states. Everything he touches relies on gold! Jeff is well aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown believes S.A.V. last week. could be "the biggest trend of the 2020s, and he's not alone. Examine out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying 2 advanced innovations: expert system and electric vehicles. Musk hopes the combination will assist him develop the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing brief of the automotive market's Holy Grail. As you understand, electric vehicles and self-driving car stocks have been big this year, but the Wall Street maker has actually been big on buzz without much concrete result. In spite of a drastic increase in competition over the past few years, Brown still believes Musk has the best opportunity of putting all of it together.
tech could be the magic string that ties everything together. S.A.V. means Shared Autonomous Automobile, and it might be the future of transport. Essentially, this technology would permit you to lease out your automobile as an autonomous, self-driving taxi when you're not utilizing it. You simply leave the car and press a button on an app that tells the automobile to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a significant chunk of the earnings. It sounds ridiculous, however it might be closed than you think.